Home › Heart Attack › Missouri
Heart Attack clinical trials in Missouri
3 studies for Heart Attack are looking for participants at sites in Missouri.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Clinical Research Consultants, Kansas City
- Kansas City VA Medical Center, Kansas City
- DCI-Rockhill, Kansas City
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- StudyMetrix Research, City of Saint Peters
- Washington Univ School Of Medicine, St Louis
- Mercy Hospital St Louis, St Louis
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Sisters of Saint Mary Health Heart and Vascular Care, Bridgeton
- Kansas City Veterans Affairs Medical Center, Kansas City
- Washington University, St Louis
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.